Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1
Clinical trial NCT01006798 · COMPLETED
Trial details
- NCT number
- NCT01006798
- Sponsor
- Emergent BioSolutions
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2011-09-01
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.